Aerosolized Ad5-nCoV booster vaccination elicited potent immune response against the SARS-CoV-2 Omicron variant after inactivated COVID-19 vaccine priming

Zhe Zhang; Shipo Wu; Yawei Liu; Kailiang Li; Pengfei Fan; Xiaohong Song; Yudong Wang; Zhenghao Zhao; Xianwei Zhang; Jin Shang; Jinlong Zhang; Jinhan Xu; Yao Li; Yaohui Li; Jipeng Zhang; Kefan Fu; Busen Wang; Meng Hao; Guanying Zhang; Pengwei Long; Ziyu Qiu; Tao Zhu; Shuling Liu; Yue Zhang; Fangze Shao; Peng Lv; Yilong Yang; Xiaofan Zhao; Yufa Sun; Lihua Hou; Wei Chen.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-22271816

Documentos relacionados

  1. Boosting with an aerosolized Ad5-nCoV elicited robust immune responses in inactivated COVID-19 vaccines recipients.
  2. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.
  3. Circular RNA vaccines against SARS-CoV-2 and emerging variants.
  4. Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity.
  5. The T cell immune response against SARS-CoV-2.
  6. T cell responses to SARS-CoV-2 spike cross-recognize Omicron.
  7. Neutralizing antibody levels associated with injectable and aerosolized Ad5-nCoV boosters and BA.2 infection.
  8. Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron.
  9. The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.
  10. Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals.